<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7983701" created="28/06/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7983701</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Inhibition of <term id="T1" lex="human_immunodeficiency_virus_type_1" sem="Virus">human immunodeficiency virus type 1</term> replication by a <term id="T2" lex="Tat-activated,_transduced_interferon_gene" sem="DNA_domain_or_region"><term id="A1" sem="Protein_molecule">Tat</term>-activated, transduced <term id="A2" sem="DNA_domain_or_region">interferon gene</term></term>: targeted expression to <term id="T3" lex="human_immunodeficiency_virus_type_1-infected_cell" sem="Cell_natural"><term id="T4" lex="human_immunodeficiency_virus_type_1" sem="Virus">human immunodeficiency virus type 1</term>-infected cells</term>.</sentence>
<event KT="Other" id="E1">
<type class="Viral_life_cycle"/>
<theme idref="T1"/>
<clue>Inhibition of human immunodeficiency virus type 1 <clueType>replication</clueType> by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.</clue>
</event>
<event KT="Other" id="E2">
<type class="Positive_regulation"/>
<theme idref="A2"/>
<cause idref="A1"/>
<clue>Inhibition of human immunodeficiency virus type 1 replication by a Tat-<clueType>activated</clueType>, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.</clue>
</event>
<event KT="Investigation" id="E3">
<type class="Negative_regulation"/>
<theme idref="E1"/>
<cause idref="E2"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> human immunodeficiency virus type 1 replication <linkCause>by</linkCause> a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.</clue>
</event>
<event KT="Investigation" id="E4">
<type class="Gene_expression"/>
<theme idref="A2"/>
<clue>Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted <clueType>expression</clueType> to <clueLoc>human immunodeficiency virus type 1-infected cells.</clueLoc></clue>
</event>
<event KT="Other" id="E51">
<type class="Viral_life_cycle"/>
<theme idref="T4"/>
<clue>Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-<clueType>infected</clueType> cells.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">We have examined the feasibility of using <term id="T5" lex="interferon_(IFN)_gene_transfer" sem="Other"><term id="T6" lex="interferon" sem="Protein_family_or_group">interferon</term> (<term id="T7" lex="IFN" sem="Protein_family_or_group">IFN</term>) gene transfer</term> as a novel approach to <term id="T8" lex="anti-human_immunodeficiency_virus_type_1_(HIV-1)_therapy" sem="Other">anti-<term id="T9" lex="human_immunodeficiency_virus_type_1" sem="Virus">human immunodeficiency virus type 1</term> (HIV-1) therapy</term> in this study.</sentence>
<sentence id="S3">To limit expression of a transduced <term id="T10" lex="HIV-1_long_terminal_repeat_(LTR)-IFNA2" sem="DNA_domain_or_region">HIV-1 long terminal repeat (LTR)-IFNA2</term> (the new approved nomenclature for <term id="T11" lex="IFN_gene" sem="DNA_family_or_group">IFN genes</term> is used throughout this article) <term id="T12" lex="hybrid_gene" sem="DNA_family_or_group">hybrid gene</term> to the <term id="T13" lex="HIV-1-infected_cell" sem="Cell_cultured">HIV-1-infected cells</term>, <term id="T14" lex="HIV-1_LTR" sem="DNA_domain_or_region">HIV-1 LTR</term> was modified.</sentence>
<event KT="Other" id="E5">
<type class="Gene_expression"/>
<theme idref="T10"/>
<clue>To limit <clueType>expression</clueType> <linkTheme>of</linkTheme> a transduced HIV-1 long terminal repeat (LTR)-IFNA2 (the new approved nomenclature for IFN genes is used throughout this article) hybrid gene to the <clueLoc>HIV-1-infected cells</clueLoc>, HIV-1 LTR was modified.</clue>
</event>
<event KT="Other" id="E52">
<type class="Viral_life_cycle"/>
<theme idref="T10"/>
<clue>To limit expression of a transduced HIV-1 long terminal repeat (LTR)-IFNA2 (the new approved nomenclature for IFN genes is used throughout this article) hybrid gene to the HIV-1-<clueType>infected</clueType> cells, HIV-1 LTR was modified.</clue>
</event>
<sentence id="S4">Deletion of the <term id="T15" lex="NF-kappa_B_element" sem="DNA_family_or_group"><term id="T16" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> elements</term> of the <term id="T17" lex="HIV-1_LTR" sem="DNA_domain_or_region">HIV-1 LTR</term> significantly inhibited <term id="T18" lex="Tat-mediated_transactivation" sem="Other"><term id="T19" lex="Tat" sem="Protein_molecule">Tat</term>-mediated transactivation</term> in <term id="T20" lex="T-cell_line" sem="Cell_cultured">T-cell lines</term>, as well as in a <term id="T21" lex="monocyte_line" sem="Cell_cultured">monocyte line</term>, <term id="T22" lex="U937" sem="Cell_cultured">U937</term>.</sentence>
<event KT="Method" id="E6">
<type class="Mutagenesis"/>
<theme idref="T15"/>
<clue><clueType>Deletion</clueType> <linkTheme>of</linkTheme> the NF-kappa B elements <clueLoc>of the HIV-1 LTR</clueLoc> significantly inhibited Tat-mediated transactivation in T-cell lines, as well as in a monocyte line, U937.</clue>
<comment>Artificial</comment></event>
<event KT="Other" id="E7">
<type class="Positive_regulation"/>
<cause idref="T19"/>
<clue>Deletion of the NF-kappa B elements of the HIV-1 LTR significantly inhibited Tat-<linkCause>mediated</linkCause> <clueType>transactivation</clueType> in T-cell lines, as well as in a monocyte line, U937.</clue>
</event>
<event Manner="High" id="E8">
<type class="Negative_regulation"/>
<theme idref="E7"/>
<cause idref="E6"/>
<clue>Deletion of the NF-kappa B elements of the HIV-1 LTR <clueManner>significantly</clueManner> <clueType>inhibited</clueType> Tat-mediated transactivation <clueLoc>in T-cell lines, as well as in a monocyte line, U937.</clueLoc></clue>
</event>
<sentence id="S5">Replacement of the <term id="T23" lex="NF-kappa_B_element" sem="DNA_domain_or_region"><term id="T24" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> elements</term> in the <term id="T25" lex="HIV-1_LTR" sem="DNA_domain_or_region">HIV-1 LTR</term> by a <term id="T26" lex="DNA_fragment" sem="DNA_molecule">DNA fragment</term> derived from the <term id="T27" lex="5&apos;-flanking_region" sem="DNA_domain_or_region">5&apos;-flanking region</term> of <term id="T28" lex="IFN-stimulated_gene_15" sem="DNA_domain_or_region">IFN-stimulated gene 15</term> (<term id="T29" lex="ISG15" sem="DNA_domain_or_region">ISG15</term>), containing the <term id="T30" lex="IFN-stimulated_response_element" sem="DNA_domain_or_region">IFN-stimulated response element</term>, partially restored <term id="T31" lex="Tat-mediated_activation" sem="Other"><term id="T32" lex="Tat" sem="Protein_molecule">Tat</term>-mediated activation</term> of <term id="T33" lex="LTR" sem="DNA_domain_or_region">LTR</term> in <term id="T34" lex="T_cell" sem="Cell_natural">T cells</term> as well as in <term id="T35" lex="monocyte" sem="Cell_natural">monocytes</term>.</sentence>
<event KT="Method" id="E9">
<type class="Mutagenesis"/>
<theme idref="T23"/>
<theme idref="T29"/>
<clue><clueType>Replacement</clueType> <linkTheme>of</linkTheme> the NF-kappa B elements <clueLoc>in the HIV-1 LTR</clueLoc> <linkTheme>by</linkTheme> a DNA fragment derived from the 5&apos;-flanking region of IFN-stimulated gene 15 (ISG15), containing the IFN-stimulated response element, partially restored Tat-mediated activation of LTR in T cells as well as in monocytes.</clue>
<comment>Artificial</comment></event>
<event id="E10">
<type class="Positive_regulation"/>
<theme idref="T33"/>
<cause idref="T32"/>
<clue>Replacement of the NF-kappa B elements in the HIV-1 LTR by a DNA fragment derived from the 5&apos;-flanking region of IFN-stimulated gene 15 (ISG15), containing the IFN-stimulated response element, partially restored Tat-<linkCause>mediated</linkCause> <clueType>activation</clueType> <linkTheme>of</linkTheme> LTR in T cells as well as in monocytes.</clue>
</event>
<event id="E11">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="E9"/>
<clue>Replacement of the NF-kappa B elements in the HIV-1 LTR by a DNA fragment derived from the 5&apos;-flanking region of IFN-stimulated gene 15 (ISG15), containing the IFN-stimulated response element, partially <clueType>restored</clueType> Tat-mediated activation of LTR <clueLoc>in T cells as well as in monocytes</clueLoc>.</clue>
</event>
<sentence id="S6">Insertion of this <term id="T36" lex="chimeric_promoter" sem="DNA_family_or_group">chimeric promoter</term> (<term id="T37" lex="ISG15_LTR" sem="DNA_domain_or_region">ISG15 LTR</term>) upstream of the <term id="T38" lex="human_IFNA2_gene" sem="DNA_domain_or_region">human IFNA2 gene</term> directed high levels of <term id="T39" lex="IFN_synthesis" sem="Other"><term id="T40" lex="IFN" sem="Protein_family_or_group">IFN</term> synthesis</term> in <term id="T41" lex="Tat-expressing_cell" sem="Cell_cultured"><term id="A24" sem="Protein_molecule">Tat</term>-expressing cells</term>, while this promoter was not responsive to <term id="T42" lex="tumor_necrosis_factor_alpha-mediated_activation" sem="Other"><term id="T43" lex="tumor_necrosis_factor_alpha" sem="Protein_molecule">tumor necrosis factor alpha</term>-mediated activation</term>.</sentence>
<event Manner="High" id="E12">
<type class="Gene_expression"/>
<theme idref="T40"/>
<clue>Insertion of this chimeric promoter (ISG15 LTR) upstream of the human IFNA2 gene directed <clueManner>high levels</clueManner> of IFN <clueType>synthesis</clueType> in Tat-expressing cells, while this promoter was not responsive to tumor necrosis factor alpha-mediated activation.</clue>
</event>
<event KT="Method" id="E13">
<type class="Mutagenesis"/>
<theme idref="T37"/>
<clue><clueType>Insertion</clueType> <linkTheme>of</linkTheme> this chimeric promoter (ISG15 LTR) <clueLoc>upstream of the human IFNA2 gene</clueLoc> directed high levels of IFN synthesis in Tat-expressing cells, while this promoter was not responsive to tumor necrosis factor alpha-mediated activation.</clue>
<comment>Artificial</comment></event>
<event id="E14">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<cause idref="E13"/>
<clue>Insertion of this chimeric promoter (ISG15 LTR) upstream of the human IFNA2 gene <clueType>directed</clueType> high levels of IFN synthesis <clueLoc>in Tat-expressing cells</clueLoc>, while this promoter was not responsive to tumor necrosis factor alpha-mediated activation.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E15">
<type class="Positive_regulation"/>
<theme idref="T37"/>
<cause idref="T43"/>
<clue>Insertion of this chimeric promoter (ISG15 LTR) upstream of the human IFNA2 gene directed high levels of IFN synthesis in Tat-expressing cells, while <corefTheme>this promoter</corefTheme> was <cluePolarity>not responsive</cluePolarity> to tumor necrosis factor alpha-<linkCause>mediated</linkCause> <clueType>activation</clueType>.</clue>
</event>
<event id="E66">
<type class="Gene_expression"/>
<theme idref="A24"/>
<clue>Insertion of this chimeric promoter (ISG15 LTR) upstream of the human IFNA2 gene directed high levels of IFN synthesis in Tat-<clueType>expressing</clueType> cells, while this promoter was not responsive to tumor necrosis factor alpha-mediated activation.</clue>
</event>
<sentence id="S7"><term id="T44" lex="ISG15-LTR-IFN_hybrid_gene" sem="DNA_domain_or_region">ISG15-LTR-IFN hybrid gene</term> inserted into the <term id="T45" lex="retrovirus_vector" sem="DNA_molecule">retrovirus vector</term> was transduced into <term id="T46" lex="Jurkat" sem="Cell_cultured">Jurkat</term> and <term id="T47" lex="U937_cell" sem="Cell_cultured">U937 cells</term>.</sentence>
<event KT="Method" id="E16">
<type class="Artificial_process"/>
<theme idref="T44"/>
<theme idref="T46"/>
<clue>ISG15-LTR-IFN hybrid gene inserted into the retrovirus vector was <clueType>transduced</clueType> <linkTheme>into</linkTheme> Jurkat and U937 cells.</clue>
</event>
<event KT="Method" id="E17">
<type class="Artificial_process"/>
<theme idref="T44"/>
<theme idref="T47"/>
<clue>ISG15-LTR-IFN hybrid gene inserted into the retrovirus vector was <clueType>transduced</clueType> <linkTheme>into</linkTheme> Jurkat and U937 cells.</clue>
</event>
<sentence id="S8">Selected <term id="T48" lex="transfected_clone" sem="Cell_cultured">transfected clones</term> produced low levels of <term id="T49" lex="IFN_A" sem="Protein_molecule">IFN A</term> (<term id="T50" lex="IFNA" sem="Protein_molecule">IFNA</term>) constitutively, and their abilities to express <term id="T51" lex="interleukin-2" sem="Protein_molecule">interleukin-2</term> and <term id="T52" lex="interleukin-2_receptor" sem="Protein_molecule"><term id="T53" lex="interleukin-2" sem="Protein_molecule">interleukin-2</term> receptor</term> upon stimulation with <term id="T54" lex="phytohemagglutinin" sem="Protein_molecule">phytohemagglutinin</term> and <term id="T55" lex="phorbol_myristate_acetate" sem="Organic_compound_other">phorbol myristate acetate</term> were retained.</sentence>
<event id="E18">
<type class="Gene_expression"/>
<theme idref="T50"/>
<clue>Selected transfected clones <clueType>produced</clueType> low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.</clue>
</event>
<event CL="L2" KT="Analysis" id="E19">
<type class="Gene_expression"/>
<theme idref="T51"/>
<clue>Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their <clueKT><clueCL>abilities</clueCL></clueKT> to <clueType>express</clueType> interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.</clue>
</event>
<event CL="L2" KT="Analysis" id="E20">
<type class="Gene_expression"/>
<theme idref="T52"/>
<clue>Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their <clueKT><clueCL>abilities</clueCL></clueKT> to <clueType>express</clueType> interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.</clue>
</event>
<event KT="Other" id="E21">
<type class="Positive_regulation"/>
<theme idref="E19"/>
<cause idref="T54"/>
<clue>Selected <clueLoc>transfected clones</clueLoc> produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon <clueType>stimulation</clueType> <linkCause>with</linkCause> phytohemagglutinin and phorbol myristate acetate were retained.</clue>
</event>
<event KT="Other" id="E22">
<type class="Positive_regulation"/>
<theme idref="E20"/>
<cause idref="T54"/>
<clue>Selected <clueLoc>transfected clones</clueLoc> produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon <clueType>stimulation</clueType> <linkCause>with</linkCause> phytohemagglutinin and phorbol myristate acetate were retained.</clue>
</event>
<event KT="Other" id="E23">
<type class="Positive_regulation"/>
<theme idref="E19"/>
<cause idref="T55"/>
<clue>Selected <clueLoc>transfected clones</clueLoc> produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon <clueType>stimulation</clueType> <linkCause>with</linkCause> phytohemagglutinin and phorbol myristate acetate were retained.</clue>
</event>
<event KT="Other" id="E24">
<type class="Positive_regulation"/>
<theme idref="E20"/>
<cause idref="T55"/>
<clue>Selected <clueLoc>transfected clones</clueLoc> produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon <clueType>stimulation</clueType> <linkCause>with</linkCause> phytohemagglutinin and phorbol myristate acetate were retained.</clue>
</event>
<sentence id="S9">Enhancement of <term id="T56" lex="IFNA_synthesis" sem="Other"><term id="T57" lex="IFNA" sem="Protein_molecule">IFNA</term> synthesis</term> observed upon <term id="T58" lex="HIV-1_infection" sem="Other"><term id="T59" lex="HIV-1" sem="Virus">HIV-1</term> infection</term> resulted in significant inhibition of <term id="T60" lex="HIV-1_replication" sem="Other"><term id="T61" lex="HIV-1" sem="Virus">HIV-1</term> replication</term> for a period of at least 30 days.</sentence>
<event id="E25">
<type class="Gene_expression"/>
<theme idref="T57"/>
<clue>Enhancement of IFNA <clueType>synthesis</clueType> observed upon HIV-1 infection resulted in significant inhibition of HIV-1 replication for a period of at least 30 days.</clue>
</event>
<event id="E26">
<type class="Initiation_of_viral_infection"/>
<theme idref="T59"/>
<clue>Enhancement of IFNA synthesis observed upon HIV-1 <clueType>infection</clueType> resulted in significant inhibition of HIV-1 replication for a period of at least 30 days.</clue>
</event>
<event id="E27">
<type class="Positive_regulation"/>
<theme idref="E25"/>
<cause idref="E26"/>
<clue><clueType>Enhancement</clueType> <linkTheme>of</linkTheme> IFNA synthesis <clueKT>observed</clueKT> <linkCause>upon</linkCause> HIV-1 infection resulted in significant inhibition of HIV-1 replication for a period of at least 30 days.</clue>
</event>
<event KT="Other" id="E28">
<type class="Viral_life_cycle"/>
<theme idref="T61"/>
<clue>Enhancement of IFNA synthesis observed upon HIV-1 infection resulted in significant inhibition of HIV-1 <clueType>replication</clueType> for a period of at least 30 days.</clue>
</event>
<event Manner="High" id="E29">
<type class="Negative_regulation"/>
<theme idref="E28"/>
<cause idref="E27"/>
<clue>Enhancement of IFNA synthesis observed upon HIV-1 infection resulted in <clueManner>significant</clueManner> <clueType>inhibition</clueType> <linkTheme>of</linkTheme> HIV-1 replication <clueTime>for a period of at least 30 days</clueTime>.</clue>
</event>
<sentence id="S10"><term id="A5" sem="Virus">Virus isolated from <term id="T62" lex="IFNA-producing_cell" sem="Cell_cultured"><term id="T63" lex="IFNA" sem="Protein_molecule">IFNA</term>-producing cells</term></term> was able to replicate in the <term id="T64" lex="U937_cell" sem="Cell_cultured">U937 cells</term> but did not replicate efficiently in <term id="T65" lex="U937_cell" sem="Cell_cultured">U937 cells</term> transduced with the <term id="T66" lex="IFNA_gene" sem="DNA_domain_or_region"><term id="T67" lex="IFNA" sem="Protein_molecule">IFNA</term> gene</term>.</sentence>
<event CL="L2" KT="Analysis" id="E30">
<type class="Viral_life_cycle"/>
<theme idref="A5"/>
<clue>Virus isolated from IFNA-producing cells was <clueKT><clueCL>able</clueCL></clueKT> to <clueType>replicate</clueType> <clueLoc>in the U937 cells</clueLoc> but did not replicate efficiently in U937 cells transduced with the IFNA gene.</clue>
<comment>TPS: A5</comment></event>
<event KT="Other" id="E70">
<type class="Gene_expression"/>
<theme idref="T63"/>
<clue>Virus isolated from IFNA-<clueType>producing</clueType> cells was able to replicate in the U937 cells but did not replicate efficiently in U937 cells transduced with the IFNA gene.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E31">
<type class="Viral_life_cycle"/>
<theme idref="A5"/>
<clue>Virus isolated from IFNA-producing cells was able to replicate in the U937 cells but did <cluePolarity>not</cluePolarity> <clueType>replicate</clueType> efficiently <clueLoc>in U937 cells transduced with the IFNA gene.</clueLoc></clue>
</event>
<event KT="Method" id="E32">
<type class="Artificial_process"/>
<theme idref="T65"/>
<theme idref="T66"/>
<clue>Virus isolated from IFNA-producing cells was able to replicate in the U937 cells but did not replicate efficiently in U937 cells <clueType>transduced</clueType> <linkTheme>with</linkTheme> the IFNA gene.</clue>
</event>
<sentence id="S11">These results suggest that targeting <term id="T68" lex="IFN_synthesis" sem="Other"><term id="T69" lex="IFN" sem="Protein_family_or_group">IFN</term> synthesis</term> to <term id="T70" lex="HIV-1-infected_cell" sem="Cell_cultured"><term id="T71" lex="HIV-1" sem="Virus">HIV-1</term>-infected cells</term> is an attainable goal and that autocrine <term id="T72" lex="IFN_synthesis" sem="Other"><term id="T73" lex="IFN" sem="Protein_family_or_group">IFN</term> synthesis</term> results in a long-lasting and permanent suppression of <term id="T74" lex="HIV-1_replication" sem="Other"><term id="T75" lex="HIV-1" sem="Virus">HIV-1</term> replication</term>.</sentence>
<event KT="Other" id="E33">
<type class="Gene_expression"/>
<theme idref="T69"/>
<clue>These results suggest that targeting IFN <clueType>synthesis</clueType> to <clueLoc>HIV-1-infected cells</clueLoc> is an attainable goal and that autocrine IFN synthesis results in a long-lasting and permanent suppression of HIV-1 replication.</clue>
</event>
<event KT="Other" id="E34">
<type class="Gene_expression"/>
<theme idref="T73"/>
<clue>These results suggest that targeting IFN synthesis to HIV-1-infected cells is an attainable goal and that autocrine IFN <clueType>synthesis</clueType> results in a long-lasting and permanent suppression of HIV-1 replication.</clue>
</event>
<event KT="Other" id="E35">
<type class="Viral_life_cycle"/>
<theme idref="T75"/>
<clue>These results suggest that targeting IFN synthesis to HIV-1-infected cells is an attainable goal and that autocrine IFN synthesis results in a long-lasting and permanent suppression of HIV-1 <clueType>replication</clueType>.</clue>
</event>
<event CL="L2" KT="Analysis" id="E36" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="E35"/>
<cause idref="E34"/>
<clue>These results <clueKT><clueCL>suggest</clueCL></clueKT> that targeting IFN synthesis to HIV-1-infected cells is an attainable goal and that autocrine IFN synthesis results in a long-lasting and permanent <clueType>suppression</clueType> <linkTheme>of</linkTheme> HIV-1 replication.</clue>
</event>
<event KT="Other" id="E71" uncertainty="probable">
<type class="Viral_life_cycle"/>
<theme idref="T71"/>
<clue>These results suggest that targeting IFN synthesis to HIV-1-<clueType>infected</clueType> cells is an attainable goal and that autocrine IFN synthesis results in a long-lasting and permanent suppression of HIV-1 replication.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
